Literature DB >> 3259051

Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

R O Dillman, A L Yu, C N Qiao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259051      PMCID: PMC1026115     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  39 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

Review 2.  Treatment of chronic lymphocytic leukemia.

Authors:  C M Huguley
Journal:  Cancer Treat Rev       Date:  1977-12       Impact factor: 12.111

3.  Proceedings: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia.

Authors:  W H Knospe; V Loeb; C M Huguley
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia.

Authors:  E Z Ezdinli; L Stutzman; C W Aungst; D Firat
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

5.  Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.

Authors:  J K Lowe; B Gowans; L Brox
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

6.  Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.

Authors:  D A Carson; J E Seegmiller
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.

Authors:  R Tung; R Silber; F Quagliata; M Conklyn; J Gottesman; R Hirschhorn
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

8.  The treatment of chronic lymphocytic leukemia with COP chemotherapy.

Authors:  M Liepman; M L Votaw
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

9.  Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia.

Authors:  A Sawitsky; K R Rai; O Glidewell; R T Silver
Journal:  Blood       Date:  1977-12       Impact factor: 22.113

10.  Low-dose deoxycoformycin in lymphoid malignancy.

Authors:  M R Grever; J M Leiby; E H Kraut; H E Wilson; J A Neidhart; R L Wall; S P Balcerzak
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

View more
  1 in total

1.  Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors.

Authors:  Marina Tusup; Thomas M Kündig; Steve Pascolo
Journal:  Mol Ther       Date:  2021-09-24       Impact factor: 11.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.